|
Market Closed -
Other stock markets
|
Pre-market 13:08:17 | |||
| 181.50 USD | -0.15% |
|
181.24 | -0.14% |
| 12-03 | Indices: oil, health, industry... very typical of Nordic indices |  |
| 12-03 | AbbVie Inc. Presents at Citi's 2024 Global Healthcare Conference, Dec-03-2024 10:15 AM |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site
| Capitalization | 321B 305B 284B 253B 451B 27,170B 495B 3,534B 1,310B 11,141B 1,205B 1,178B 47,956B | P/E ratio 2024 * |
38.2x | P/E ratio 2025 * | 25.2x |
|---|---|---|---|---|---|
| Enterprise value | 378B 360B 335B 299B 532B 32,052B 584B 4,169B 1,546B 13,143B 1,422B 1,390B 56,572B | EV / Sales 2024 * |
6.75x | EV / Sales 2025 * | 6.25x |
| Free-Float |
96.39% | Yield 2024 * |
3.43% | Yield 2025 * | 3.6% |
More valuation ratios
* Estimated data
More news
Last Transcript: AbbVie Inc.
More recommendations
More press releases
More news
| 1 day | -0.14% | ||
| 1 week | +0.20% | ||
| Current month | -0.78% | ||
| 1 month | -10.83% | ||
| 3 months | -8.19% | ||
| 6 months | +13.30% | ||
| Current year | +17.12% |
1 week
178.86
183.54
1 month
163.81206.15
Current year
153.58207.32
1 year
142.66207.32
3 years
119.21207.32
5 years
62.55207.32
10 years
45.45207.32
| Director | Title | Age | Since |
|---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 53 | 30/06/2024 |
Scott Reents
DFI | Director of Finance/CFO | 57 | 22/06/2022 |
Roopal Thakkar
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2002 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Gonzalez
CHM | Chairman | 70 | 31/12/2012 |
Roxanne Austin
BRD | Director/Board Member | 63 | 31/12/2012 |
William Burnside
BRD | Director/Board Member | 72 | 31/12/2012 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 7.12% | 7 M€ | +21.18% | - | |
| 6.85% | 20 M€ | +16.48% | - | |
| 6.26% | 13 M€ | -.--% |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -0.15% | +0.20% | +26.56% | +52.71% | 321B | ||
| +1.69% | +3.04% | +39.26% | +231.19% | 732B | ||
| -0.16% | +4.60% | +12.34% | +119.48% | 488B | ||
| -1.58% | -1.40% | -3.80% | -4.40% | 367B | ||
| +1.23% | +0.23% | -1.56% | +38.87% | 258B | ||
| -0.10% | +0.63% | +3.17% | -30.87% | 231B | ||
| -2.46% | -2.25% | +5.25% | +21.48% | 210B | ||
| -2.60% | -0.25% | +2.34% | +25.62% | 212B | ||
| +0.08% | -0.60% | +2.15% | +37.48% | 150B | ||
| -1.01% | -0.81% | -11.59% | -52.90% | 145B | ||
| Average | -0.66% | +0.42% | +7.41% | +43.87% | 311.19B | |
| Weighted average by Cap. | -0.19% | +1.14% | +13.65% | +81.51% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 56.04B 53.31B 49.66B 44.26B 78.83B 4,747B 86.54B 617B 229B 1,947B 211B 206B 8,378B | 59.1B 56.22B 52.37B 46.68B 83.14B 5,007B 91.28B 651B 241B 2,053B 222B 217B 8,837B |
| Net income | 8.25B 7.85B 7.31B 6.52B 11.61B 699B 12.74B 90.9B 33.7B 287B 31B 30.31B 1,234B | 12.02B 11.43B 10.65B 9.49B 16.91B 1,018B 18.56B 132B 49.09B 417B 45.16B 44.15B 1,797B |
| Net Debt | 57.63B 54.82B 51.07B 45.52B 81.07B 4,882B 89B 635B 235B 2,002B 217B 212B 8,617B | 48.73B 46.36B 43.18B 38.49B 68.56B 4,128B 75.26B 537B 199B 1,693B 183B 179B 7,287B |
More financial data
* Estimated data
Employees
50,000
Sector
Pharmaceuticals
Calendar
14/01/2025
- Détachement de
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/12/24 | 181.50 $ | -0.15% | 4,107,553 |
| 02/12/24 | 181.77 $ | -0.63% | 3,936,877 |
| 29/11/24 | 182.93 $ | -0.08% | 2,710,732 |
| 27/11/24 | 183.08 $ | +1.07% | 5,271,481 |
| 26/11/24 | 181.14 $ | +2.30% | 6,947,512 |
Delayed Quote Nyse, December 03, 2024 at 09:00 pm
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
181.50USD
Average target price
204.48USD
Spread / Average Target
+12.66%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ABBV Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition